Nanotechnology Now - Press Release: BioForce Makes Forbes/Wolfe List of Nanotech Stocks To Watch

Home > Press > BioForce Makes Forbes/Wolfe List of Nanotech Stocks To Watch

Abstract:
BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH.OB), today comments on making the
"Class of 2006" list of nanotech stocks to watch. Found on Forbes.com, the list is an update of a scorecard the Forbes/Wolfe Nanotech Report developed some years ago. It names BioForce among 20 nano-related companies to keep an eye on, while cautioning that inclusion isn't a recommendation.

BioForce Makes Forbes/Wolfe List of Nanotech Stocks To Watch

AMES, IA | Posted on February 2nd, 2007

"We've believed all along that our surface patterning technology is new
and exciting," notes BioForce's Kerry Frey, chief operating officer. "The
variety of research being conducted utilizing nanotechnology as the
standard has exploded. Our niche in the life sciences discipline is a
strategic move as biosensors and nanosensors move from academic R&D into
commercial product development." BioForce only entered public trading in
March 2006 but has been in business since 1994. The bulk of BioForce's
business falls under its wholly owned subsidiary, BioForce Nanosciences,
Inc. Their flagship product, the Nano eNabler(TM) system, is a benchtop
molecular printer that places tiny domains of biological materials onto
surfaces with nanometer spatial precision.
The Forbes/Wolfe report states that 2006 wasn't a banner year for
nanotech stocks, but assures that for the patient investor, rewards are on
the horizon for nanotech and nano-related stocks. The life sciences
discipline is receiving positive reports as well. For example, Ernst &
Young, LLP reported in 2006 that the American biotechnology industry has
surpassed pharmaceutical companies for the third straight year as the
primary source of new medicines, and biotech revenue jumped nearly 16
percent to a record $50.7 billion in 2005.

####

About BioForce
BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH.OB) is
the parent company of BioForce Nanosciences, Inc. BioForce Nanosciences is
a unique company entering into commercialization with over a decade of
research and accomplishment in the field of bionanotechnology. BioForce has
demonstrated the ability to take a product from concept to commercial sale.
For more information, visit http://www.bioforcenano.com .
This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the Company's most recent filings with the
Securities and Exchange Commission. The Company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.

For more information, please click here

Contacts:
BioForce Nanosciences, Inc.
1615 Golden Aspen Drive, Suite 101
Ames, IA 50010 USA

Phone: 515.233.8333
Fax: 515.233.8337
E-mail:

Investor Relations
Phone: 515.233.8333 ext. 101
Fax: 515.233.8337
E-mail: